The clinical pharmacology of beta-adrenoceptor-blocking drugs.
about
Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertensionThe effect of chronic propranolol treatment on overnight plasma levels of anterior pituitary and related hormones.Improved physical performance as a therapeutic objective in patients with angina.Beta-blockers in bronchial asthma: effect of propranolol and pindolol on large and small airwaysbeta 2-Adrenoceptors regulate induction of myocardial ornithine decarboxylase in mice in vivoLow-dose propranolol for the protection of the left ventricle from ischaemic damageHaemodynamic effects of acute beta-adrenergic receptor blockade in congestive cardiomyopathyAngina pectoris: effective therapy once daily.Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate)Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs.Right ventricular performance in essential hypertension after beta-blockade.Improved myocardial lactate extraction after propranolol in coronary artery disease: effected by peripheral glutamate and free fatty acid metabolism.Influence of intrinsic sympathomimetic activity on respiratory function during chronic beta blockade: comparison of propranolol and pindolol.Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).Beta-adrenoceptors in human lung, bronchus and lymphocytes.Regional myocardial tissue blood flow during sequential beta 1- and beta 2-adrenergic blockade in cat hearts with acute ischaemia.
P2860
Q28332357-579843A5-3820-4183-ACB7-E363ABAFB97BQ34449576-724DEA10-F4F8-4E27-91E1-5E51E89F7885Q34516462-199694D8-159B-48D7-A419-CB9B63520D51Q36126404-6E3359AC-CD8C-4108-8417-0B1681B3B146Q36128043-42EBC84A-6684-4303-8F6D-1CA6A75E8A0AQ36477940-5941BBC7-1839-4F27-8261-0A7E8B74F3F4Q36767210-E35C15C0-9216-48FB-9ABC-ACDD0D63E27EQ39238448-2E983400-15E6-42BA-AE36-B30B7758CC13Q39261728-170E0491-9EBE-412A-87C8-4AC268CDA99CQ39722587-C2923D2A-94FD-432E-94AA-74AC23193F3EQ41321470-44CAFD1B-7F2E-42E9-A94C-FCC46025797EQ43016178-7ACF1A32-9CB8-47B7-8470-5F6096214E80Q43173913-C3529E7F-F59D-486C-A151-F44519C4535FQ43241458-37D6EB0E-5A73-4229-A1B7-528140326B66Q43242643-A09EA51D-5E69-4691-875B-47CF3643592EQ54487330-AF4531A1-32C0-435A-99CA-4716025CAB3E
P2860
The clinical pharmacology of beta-adrenoceptor-blocking drugs.
description
1976 nî lūn-bûn
@nan
1976 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
The clinical pharmacology of beta-adrenoceptor-blocking drugs.
@ast
The clinical pharmacology of beta-adrenoceptor-blocking drugs.
@en
type
label
The clinical pharmacology of beta-adrenoceptor-blocking drugs.
@ast
The clinical pharmacology of beta-adrenoceptor-blocking drugs.
@en
prefLabel
The clinical pharmacology of beta-adrenoceptor-blocking drugs.
@ast
The clinical pharmacology of beta-adrenoceptor-blocking drugs.
@en
P2093
P1476
The clinical pharmacology of beta-adrenoceptor-blocking drugs.
@en
P2093
Conolly ME
Dollery CT
Kersting F
P304
P356
10.1016/0033-0620(76)90016-5
P577
1976-11-01T00:00:00Z